- Home
- Services
- usa new york
- clinical data on brain development
Show results for
Refine by
Clinical Data On Brain Development Services In Usa New York
11 services found
Manufactured by:Rocket Pharmaceuticals, Inc. based inCranbury, NEW JERSEY (USA)
Rocket’s Research and Discovery group in the Cranbury, New Jersey facility utilizes approximately 20,000 square feet of state-of-the-art laboratories for designing, optimizing and advancing candidate therapeutics to clinical stage ...
Manufactured by:Creative Biostructure based inShirley, NEW YORK (USA)
The formation of virus-like particles (VLPs) is a result of self-assembly of one or several types of viral structural proteins, such as Envelope or Capsid. The component proteins can originate from different viruses or be recombinantly expressed. Various systems have been used in the successful construction of VLPs from different sources including bacterial, yeast, insect cells, plant and ...
Manufactured by:CD Formulation based inShirley, NEW YORK (USA)
Antibacterial, anti-inflammatory, and antiviral drugs are commonly used clinically. However, with the spread and evolution of drug resistance, the efficacy of these drugs, especially antibacterial and antiviral drugs, is declining. At present, there is no effective means to deal with the problem of drug resistance clinically, and the development of new drugs is urgently needed. CD Formulation ...
Manufactured by:Creative Bioarray based inShirley, NEW YORK (USA)
Hepatotoxicity is one of the major reason for drug withdrawal from pharmaceutical development and clinical use. In vitro hepatotoxicity assays mimic in vivo tissue studies and in turn provide a reliable tool for safety assessment in the early stages of drug development. Creative Bioarray has developed standard and innovative in vitro models to address the need for early stage hepatotoxicity ...
Manufactured by:Alfa Chemistry based inNY, NEW YORK (USA)
One of the most important steps in the process of developing a medicine is determining its safety. Alfa Chemistry is dedicated to providing pre-clinical drug research services to support our clients' drug development, pre-clinical and clinical investigations, and assist them in deciding which drug candidates are most worthwhile to pursue in clinical trials. We emphasize pharmacology, ...
Manufactured by:Pluristem Therapeutics Inc. based inHaifa, ISRAEL
Graft Versus Host Disease (GvHD) is a potentially lethal complication of hematopoietic cell transplantation (HCT) from a donor. When a patient receives a donor’s stem cells, the transplanted cells may identify the patient’s body as foreign and attack it. The chronic form of GvHD occurs at least 100 days following the transplantation. The GvHD market is predicted to exceed $500 million ...
Manufactured by:Pluristem Therapeutics Inc. based inHaifa, ISRAEL
Pluristem’s goal is to provide patients, physicians and healthcare systems around the globe with standardized, easy to use and highly effective PLX cell products that need no genetic or tissue matching prior to administration. We are active with many respectful regulatory agencies worldwide to advance our clinical programs towards marketing. Part of our clinical development strategy is to ...
Manufactured by:KSL Biomedical based inBuffalo, NEW YORK (USA)
KSL Biomedical, Inc. (“KSL”) was founded to deliver innovative diagnostics and therapeutics. KSL has professionals with many decades of experience in US and international regulatory compliance, product design and development, clinical trials, and protection of intellectual property to work with health care industry partners to address their need for special resources to achieve and ...
Manufactured by:Pluristem Therapeutics Inc. based inHaifa, ISRAEL
COVID-19 is caused by infection with the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that may cause clusters of severe respiratory illness associated with the need for intensive care unit (ICU) admission and high mortality. Studies have shown that Acute Respiratory Distress Syndrome (ARDS) following viral pneumonia is one of the most common causes of death from ...
Manufactured by:Pluristem Therapeutics Inc. based inHaifa, ISRAEL
Femoral neck fracture is the most common form of hip fracture with annual treatment costs in the U.S. estimated to be between $10 to $15 billion, and are expected to rise due to the aging population, with mortality rates of up to 36%. *click for further information about Muscle injury due to total hip ...
Manufactured by:Mesothelioma + Asbestos Awareness Center based inSyracuse, NEW YORK (USA)
There is no cure for mesothelioma, but clinical trials and experimental treatments offer hope for the future. In the never-ending effort to eradicate cancer, there are medical and scientific researchers constantly looking for new ways to attack this deadly disease. Many of the commonly used methods of treating cancer today were once experimental, and the hope is that new, even more effective ...